Life Sciences

Promoting enrollment in affordable health care insurance brings wider gains. Commonwealth of Kentucky client spotlight

Learn how Deloitte helped the state of Kentucky build a technical architecture to allow holistic integration of health info.

1.20 MB
add to cart
pdf preview

Life Sciences

Operating under a Consent Decree Managing a Life Sciences company through a major regulatory action

Through planning and commitment, your company can mitigate the near-term disruptions caused by a Consent Decree and eventually emerge as a stronger, more compliant, and quality conscious company, well-positioned for long-term success.

573.21 KB
add to cart
pdf preview

Life Sciences

In the face of uncertainty: A challenging future for biopharmaceutical innovation

The biopharma industry is in a precarious position regarding innovation: big bets in bold new areas are leading to complexity & uncertainty.

438.08 KB
add to cart
pdf preview

Life Sciences

Deloitte SolutionPrint™ for Life Sciences

Deloitte SolutionPrint™ for Life Sciences accelerates Process Transformation enabled by Oracle software which facilitates business adoption and provides a platform for growth and scale globally. Learn more.

1.02 MB
add to cart
pdf preview

Life Sciences

Meeting compliance challenges: Leveraging the value of outsourcing

This white paper focuses on how compliance outsourcing can help organizations to address compliance demands while staying focused on their core business functions and go-to-market strategies.

385.75 KB
add to cart
pdf preview

Life Sciences

Impact of European austerity on pharmaceutical policy and pricing

A UK Deloitte Centre for Health solutions report that looks to understand the current European pharmaceutical market, the mechanisms for reducing pharmaceutical spending, the future of the pharmaceutical landscape, and the actions the pharmaceutical industry needs to take to survive current austerity.

3.26 MB
add to cart
pdf preview

Life Sciences

Big Pharma: Business model choices for the new market

The pharmaceutical industry faces a critical need for change. The unsustainable trajectory of health care spending and a wave of regulatory reforms have triggered forces that are transforming the pharmaceutical landscape.

964.04 KB
add to cart
pdf preview